NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · IEX Real-Time Price · USD
3.135
+0.495 (18.75%)
At close: Jul 26, 2024, 3:59 PM
3.080
-0.055 (-1.75%)
After-hours: Jul 26, 2024, 7:56 PM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $19.55 million as of July 26, 2024. Its market cap has increased by 55.20% in one year.
Market Cap
19.55M
Enterprise Value
20.21M
1-Year Change
55.20%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $30.60M to $19.55M, a decrease of -36.10%. That is a compound annual growth rate of -15.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 16.60M | 36.07% |
| Dec 29, 2023 | 12.20M | 74.29% |
| Dec 30, 2022 | 7.00M | -46.97% |
| Dec 31, 2021 | 13.20M | -56.87% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 17.33M |
| PharmaCyte Biotech | 17.08M |
| Sensei Biotherapeutics | 17.02M |
| Aeterna Zentaris | 16.99M |
| Chemomab Therapeutics | 16.92M |
| Biotricity | 16.53M |
| Edesa Biotech | 16.43M |
| TRxADE HEALTH | 16.36M |